SmartBio Analytics provides biomarker analysis services for pharmaceutical, biotechnology and research organisations. Using advanced analytical technologies and validated methodologies, we deliver accurate, sensitive and reliable biomarker data to support preclinical and clinical development programmes.
We quantify both endogenous and exogenous biomarkers across a wide variety of therapeutic areas, supporting discovery, preclinical, and clinical programs.
We have extensive experience in the quantification of steroids as biomarkers in multiple therapeutic areas, including endocrinology, oncology, neurology, and metabolic diseases. Our LC/MS-based methods allow for high sensitivity, specificity, and multiplexing capabilities, enabling simultaneous measurement of multiple steroid hormones in a single run.
In addition to steroids, our expertise covers:
Results typically within 5 days of sample receipt
LC/MS technology overcomes cross-reactivity issues common in immunoassays
Full alignment with QA & Certifications requirements for regulatory submissions
From small molecules to complex biomolecules
See our Non-Proprietary Assays for validated biomarker methods available
Meet the scientists behind our biomarker projects on our Team page
With SmartBio Analytics, biomarker analysis becomes faster, more reliable, and fully tailored to your project’s scientific and regulatory needs — helping you turn biomarker data into actionable insights.
